Laura Gilardi

858 total citations
36 papers, 514 citations indexed

About

Laura Gilardi is a scholar working on Surgery, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Laura Gilardi has authored 36 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Oncology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Laura Gilardi's work include Medical Imaging Techniques and Applications (12 papers), Breast Cancer Treatment Studies (8 papers) and Breast Lesions and Carcinomas (6 papers). Laura Gilardi is often cited by papers focused on Medical Imaging Techniques and Applications (12 papers), Breast Cancer Treatment Studies (8 papers) and Breast Lesions and Carcinomas (6 papers). Laura Gilardi collaborates with scholars based in Italy, United States and United Kingdom. Laura Gilardi's co-authors include Giovanni Paganelli, Chiara Maria Grana, Marzia Colandrea, Lisa Bodei, Laura Lavinia Travaini, Maddalena Sansovini, Francesco Ceci, Oriana Nanni, Annarita Ianniello and Mahila Ferrari and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Advanced Science and Annals of Surgical Oncology.

In The Last Decade

Laura Gilardi

34 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Gilardi Italy 11 309 195 158 148 102 36 514
Munetaka Takekuma Japan 15 196 0.6× 199 1.0× 123 0.8× 39 0.3× 234 2.3× 60 780
Andréa Moretti Italy 14 208 0.7× 118 0.6× 213 1.3× 78 0.5× 63 0.6× 36 650
Raffaele Solla Italy 12 160 0.5× 57 0.3× 138 0.9× 51 0.3× 95 0.9× 24 480
Johan C. van Mourik Netherlands 12 200 0.6× 176 0.9× 88 0.6× 79 0.5× 187 1.8× 21 637
Shamim Ahmed Shamim India 12 109 0.4× 67 0.3× 187 1.2× 63 0.4× 120 1.2× 73 476
Kazumasa Odagiri Japan 10 83 0.3× 58 0.3× 66 0.4× 54 0.4× 100 1.0× 14 323
Varaha S. Tammisetti United States 10 112 0.4× 84 0.4× 106 0.7× 37 0.3× 159 1.6× 20 410
Noriko Ii Japan 13 146 0.5× 78 0.4× 74 0.5× 42 0.3× 185 1.8× 40 519
A. Farella Italy 12 121 0.4× 47 0.2× 112 0.7× 50 0.3× 167 1.6× 22 446
Francesca Torello Viera Italy 10 142 0.5× 264 1.4× 50 0.3× 25 0.2× 152 1.5× 23 521

Countries citing papers authored by Laura Gilardi

Since Specialization
Citations

This map shows the geographic impact of Laura Gilardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Gilardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Gilardi more than expected).

Fields of papers citing papers by Laura Gilardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Gilardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Gilardi. The network helps show where Laura Gilardi may publish in the future.

Co-authorship network of co-authors of Laura Gilardi

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Gilardi. A scholar is included among the top collaborators of Laura Gilardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Gilardi. Laura Gilardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilardi, Laura, et al.. (2024). Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives. Current Opinion in Oncology. 36(6). 514–520. 1 indexed citations
2.
Confalonieri, Stefano, Rosa Pennisi, Agnese De Mario, et al.. (2024). A PET‐Surrogate Signature for the Interrogation of the Metabolic Status of Breast Cancers. Advanced Science. 11(28). e2308255–e2308255. 2 indexed citations
3.
Gilardi, Laura, et al.. (2023). FDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast Carcinoma. Biomedicines. 11(5). 1350–1350. 8 indexed citations
4.
Demirci, Emre, et al.. (2022). Radiolabeled FAP inhibitors as new pantumoral radiopharmaceuticals for PET imaging: a pictorial essay. Clinical and Translational Imaging. 11(1). 95–106. 3 indexed citations
5.
Magnoni, Francesca, Giovanni Corso, Laura Gilardi, et al.. (2021). Does Failed Mapping Predict Sentinel Lymph Node Metastasis in cN0 Breast Cancer?. Future Oncology. 18(2). 193–204. 4 indexed citations
6.
Corso, Giovanni, Francesca Magnoni, Elena Provenzano, et al.. (2020). Multicentric breast cancer with heterogeneous histopathology: a multidisciplinary review. Future Oncology. 16(8). 395–412. 9 indexed citations
7.
Garibaldi, Cristina, Sara Ronchi, Marta Cremonesi, et al.. (2017). Interim 18 F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics. 98(3). 555–573. 28 indexed citations
8.
Cremonesi, Marta, Laura Gilardi, Mahila Ferrari, et al.. (2017). Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review. European Journal of Nuclear Medicine and Molecular Imaging. 44(11). 1915–1927. 42 indexed citations
9.
Ferrari, Mahila, Laura Lavinia Travaini, D. Ciardo, et al.. (2017). Interim 18FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic review. Critical Reviews in Oncology/Hematology. 113. 28–42. 8 indexed citations
10.
Gilardi, Laura, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 329–329. 4 indexed citations
11.
Gilardi, Laura, et al.. (2016). Multiple vertebral hemangiomas: a potential pitfall in 68Ga-DOTATOC PET/CT interpretation. Endocrine. 55(3). 992–993. 4 indexed citations
12.
Gilardi, Laura, et al.. (2016). Isolated Metachronous Splenic Metastasis From Colon Cancer Found by 18F-FDG PET/CT. Clinical Nuclear Medicine. 42(1). 79–80. 8 indexed citations
13.
Travaini, Laura Lavinia, Maria Giulia Zampino, Marzia Colandrea, et al.. (2016). PET/CT with Fluorodeoxyglucose During Neoadjuvant. ecancermedicalscience. 10. 629–629. 8 indexed citations
14.
Mariniello, Annapaola, Lisa Bodei, Carmine Tinelli, et al.. (2015). Long-term results of PRRT in advanced bronchopulmonary carcinoid. European Journal of Nuclear Medicine and Molecular Imaging. 43(3). 441–452. 88 indexed citations
15.
Severi, Stefano, Oriana Nanni, Lisa Bodei, et al.. (2013). Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. 40(6). 881–888. 91 indexed citations
16.
Gilardi, Laura, et al.. (2013). Ipilimumab-Induced Immunomediated Adverse Events. Clinical Nuclear Medicine. 39(5). 472–474. 14 indexed citations
17.
Cicco, Concetta De, Laura Gilardi, Edoardo Botteri, et al.. (2012). Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?. The Breast. 22(1). 39–43. 26 indexed citations
18.
Gilardi, Laura, Concetta De Cicco, Marco Colleoni, et al.. (2010). Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy. European Journal of Nuclear Medicine and Molecular Imaging. 37(10). 1834–1841. 6 indexed citations
19.
Gilardi, Laura, et al.. (2009). Salivary glands imaging. 59(1). 43–51. 1 indexed citations
20.
Ferrari, Daris, Claudia Carbone, Luca Fumagalli, et al.. (2006). Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity. Anti-Cancer Drugs. 17(3). 359–361. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Munetaka Takekuma Breakdown of academic impact, for papers by Andréa Moretti Breakdown of academic impact, for papers by Raffaele Solla Breakdown of academic impact, for papers by Johan C. van Mourik Breakdown of academic impact, for papers by Shamim Ahmed Shamim Breakdown of academic impact, for papers by Kazumasa Odagiri Breakdown of academic impact, for papers by Varaha S. Tammisetti Breakdown of academic impact, for papers by Noriko Ii Breakdown of academic impact, for papers by A. Farella Breakdown of academic impact, for papers by Francesca Torello Viera
Rankless by CCL
2026